Back

Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel risk predictors in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Itsuki Osawa

Columbia University Irving Medical Centre, New York (United States of America)

5 More presentations in this session

Presentation thumbnail
Prediction of family inheritance in non-sarcomeric hypertrophic cardiomyopathy using clinical variables and 12-lead electrocardiogram artificial intelligence models
Doctor M. Tremblay-Gravel (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Genotype predicts heart failure independent of left ventricular ejection fraction and NT-proBNP levels in hypertrophic cardiomyopathy
Doctor A. Bakalakos (London, GB)
Abstract Slides Video
Presentation thumbnail
Impaired myocardial energetics in both sarcomere positive and negative HCM are linked to arrhythmic risk
Doctor Z. Ashkir (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Myocardial scar in end-stage hypertrophic cardiomyopathy: correlation with systolic function and prognostic significance.
Doctor R. Ditaranto (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study
Doctor M. Jensovsky (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Novel risk predictors in hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources